Karachi, The Searle Company Limited, a prominent pharmaceutical company, is pleased to announce a significant milestone in its global expansion strategy. The Ministry of Health and Prevention in the United Arab Emirates (UAE) has officially approved and registered the manufacturing site of the Company.
This achievement reflects Searle’s commitment to enhancing its presence and capabilities in various regions across the globe. The Company has been rapidly expanding its operations in numerous international markets, including South Asia, Southeast Asia, Africa, Francophone Africa, GCC (Gulf Cooperation Council), Commonwealth of Independent States (CIS), Canada, Europe, and Latin America (EU&LATAM).
The approval from the UAE Ministry of Health and Prevention is a testament to Searle’s dedication to maintaining the highest standards of quality and compliance in the pharmaceutical industry. This milestone not only strengthens the Company’s foothold in the UAE market but also underscores its position as a trusted provider of pharmaceutical products and services worldwide.
Searle’s ongoing commitment to innovation, quality, and international expansion aligns with its mission to improve access to healthcare and enhance the well-being of communities around the world. The Company’s efforts to expand its manufacturing capabilities and achieve regulatory approvals reflect its vision for sustainable growth and global impact in the pharmaceutical sector.
The post Searle Company Limited Achieves Approval for Manufacturing Site from UAE Ministry of Health and Prevention appeared first on Pakistan Company News.
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service